Abstract
Purpose
We tested the hypothesis that the application of intranasal oxytocin (8 IU) following intrauterine insemination (IUI) would increase pregnancy rates, without causing major side effects.
Methods
Randomized, double-blind, placebo-controlled pilot study: eighty-six couples with idiopathic infertility, polycystic ovary syndrome and/or male sub-fertility treated with 132 homologous IUI cycles with nasal application of placebo or 8 IU oxytocin following IUI.
Results
In 132 IUI cycles of 86 women, 17 pregnancies were achieved, accounting for a pregnancy rate of 12.9% (17/132) per IUI cycle. The pregnancy rates were 13.4% (9/67) per IUI cycle in the placebo group, and 12.3% (8/65) per IUI cycle in the oxytocin group, the difference not being statistically significant. No relevant side effects were observed in both groups.
Conclusions
Intranasal application of 8 IU oxytocin has no major side effects but at the same time did not affect pregnancy rates after IUI in our population. This study does not exclude that a larger patient group, a different time interval between oxytocin application and IUI, higher or multiple oxytocin applications or a different mode of application would have achieved different effects on pregnancy rates.
Similar content being viewed by others
References
Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J (2000) Intrauterine insemination or in vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355:13–18
Duran HE, Morshedi M, Kruger T, Oehninger S (2002) Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 8:373–384
Allen NC, Herbert CM III, Maxson WS, Rogers BJ, Diamond MP, Wentz AC (1985) Intrauterine insemination: a critical review. Fertil Steril 44:569–580
Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G (1996) The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 11:627–632
Kunz G, Beil D, Deininger H, Einspanier A, Mall G, Leyendecker G (1997) The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 424:267–277
Leyendecker C, Kunz G, Wildt L, Beil D, Deininger H (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 11:1542–1551
Wildt L, Kissler S, Licht P, Becker W (1998) Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingoscintigraphy and Doppler sonography. Hum Reprod Update 4:655–666
Kunz G, Noe M, Herbertz M, Leyendecker G (1998) Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update 4:647–654
Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function and regulation. Physiol Rev 81:629–683
Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM (1987) Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab 64:27–31
Kunz G (2007) Oxytocin—a stimulator of directed sperm transport in humans. Reprod Biomed Online 14:32–39
Zervomanolakis I, Ott HW, Hadziomerovic D, Mattle V, Seeber BE, Virgolini I, Heute D, Kissler S, Leyendecker G, Wildt L (2007) Physiology of upward transport in the human female genital tract. Ann NY Acad Sci 1101:1–20
Du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S (1953) The synthesis of oxytocin. J Am Chem Soc 75:4879–4880
Zingg HH, Rozen F, Chu K, Larcher A, Arslan A, Richard S, Lefèbvre D (1995) Oxytocin and oxytocin receptor gene expression in the uterus. Recent Prog Horm Res 50:255–273
Takeda S, Kuwabara Y, Mizuno M (1989) Metabolic clearance rate of oxytocin in human subjects. Nippon Naibunpi Gakkai Zasshi 65:182–189
Reyden G, Sjöholm I (1971) The metabolism of oxytocin in pregnant and non-pregnant women. Acta Obstet Gynecol Scand Suppl Suppl 9:37
Baumgarten K, Hofhansl W (1959) Synthocinon in the therapy and prophylaxis of mastitis puerperalis. Geburtshilfe Frauenheilk 19:913–921
Hendricks CH, Pose SV (1961) Intranasal oxytocin in obstetrics. JAMA 175:384–387
Pena FJ, Dominguez JC, Carbajo M, Anel L, Alegre B (1998) Treatment of swine summer infertility syndrome by means of oxytocin under field conditions. Theriogenology 49:829–836
Rasch K, Schoon HA, Sieme H, Klug E (1996) Histomorphological endometrial status and influence of oxytocin in the uterine drainage and pregnancy rate in mares. Equine Vet J 28:455–460
Landgraf R (1985) Plasma oxytocin concentration in man after different routes of administration of synthetic oxytocin. Exp Clin Endocrinol 85:245–248
Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC (1999) The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest 47:125–126
HO W (1999) Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge University Press, Cambridge
Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B (1996) Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum Reprod 11:1892–1896
Ombelet W, Vandeput H, Van der Putte G, Cox A, Janssen M, Jacobs P, Bosmans E, Steeno O, Kruger T (1997) Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology. Hum Reprod 12:1458–1463
Campana A, Sakkas D, Stalberg A, Bianchi PG, Comte I, Pache T, Walker D (1996) Intrauterine insemination: evaluation of the results according to woman’s age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 11:732–736
Acknowledgments
We are grateful to Heidi Ritzerfeld and Katharina-Barbara Linke (Department of Obstetrics and Gynecology, Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany) for their expert technical assistance and to Dr. Markus Möschl (Pharmacy Department, Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany) for preparation of the nasal sprays and blinding and to Dr. Alexander Crispin and Prof. Jutta Engel (Department of Medical Informatics, Biometrics and Epidemiology, Munich, Germany) for statistical support and Dr. Margarita Summerer-Moustaki for language editing.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ochsenkühn, R., Pavlik, R., Hecht, S. et al. The effect of nasal oxytocin on pregnancy rates following intrauterine insemination: double-blind, randomized, clinical pilot study. Arch Gynecol Obstet 281, 753–759 (2010). https://doi.org/10.1007/s00404-009-1284-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-009-1284-9